Recalls / Active ingredient / Tazobactam Sodium
Tazobactam Sodium
3 FDA drug recalls involving the active ingredient “Tazobactam Sodium” — 2 Class I.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2020-12-21 | Class II | Zerbaxa (ceftolozane and tazobactam) 1.5g per vial for injection, Single-Dose vial, Rx only, Manuf. for: Merck | Merck Sharp & Dohme |
| 2018-07-02 | Class I | Piperacillin and Tazobactam for Injection USP 3.375 grams per vial, Single-Dose Vial, Rx Only. Manufactured fo | AuroMedics Pharma LLC |
| 2018-05-01 | Class I | Piperacillin and Tazobactam for Injection, USP 3.375 grams per vial, For Intravenous Use Only, Single-Dose via | AuroMedics Pharma LLC |